Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences

Cognizant announced a five-year extension of its work with Gilead Sciences , a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. Under the agreement, Cognizant will support Gilead’s continued development of DevOps capabilities and the responsible application of agentic AI tools across selected technology programs. Cognizant will apply its life sciences and technology experience to support Gilead’s development and operations environment